RepaGlinide BEKER ® is an oral diabetes medicine, indicated for the treatment of Type 2 diabetes, when high blood sugar can no longer be satisfactorily controlled through diet, exercise and weight loss. Repaglinide is also indicated in combination with metformin in adult type 2 diabetics who are not satisfactorily balanced with metformin alone.
| DCI | REPAGLINIDE |
|---|---|
| Dosage | 01 mg |
| Trade name | REPAGLINIDE BEKER® |
| Name of the originator | Novoform |
| Presentation | 30 tablets |
| Specialty | Métabolisme – ADO |
